| ART | Anti-retroviral therapy |
| HIV | Human immunodeficiency virus |
| HSCs | Hematopoietic stem cells |
| LRA | Latency-reversing agents |
| HMG | High-mobility group |
| TCR | T cell receptor |
| LncRNA | Long noncoding RNA |
| BLT | Bone marrow, liver, and thymus |
| MDCs | Monocyte-derived dendritic cells |
| TLRs | Toll-like receptors |
| NLS | Nuclear localization signal |
| NHEJ | Nonhomologous end joining |
| PIR | Pro-Trp-Trp-Pro motif interacting region |
| TOX | Thymocyte selection-associated high-mobility group box |
| HMGB1 | High-mobility group box 1 |
| LPS | lipopolysaccharides |
| mTOR | Mammalian target of Rapamycin |
| JAK | Janus kinase |
| STAT | Signal transducer and activator of transcription |
| PD-1 | Programmed cell death-1 |
| QUECEL | Quiescent effector cell latency |
| LTR | Long terminal repeats |
| RNAPII | RNA polymerase II |
| SNP | Single nucleotide polymorphisms |
| TREM1 | Triggering receptor expressed on myeloid cells 1 |
| mAb | Monoclonal antibody |
| dCA | didehydro-Cortistatin A |
| NK | Natural killer |